Skip to content

Author

Ming-Ming Hu

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Sitagliptin for Acute Graft-Versus-Host Disease Prevention in Alternative Donor Transplantation: A Randomized Phase III Trial.

PURPOSE This trial evaluated whether the addition of sitagliptin to antithymocyte globulin (ATG)-based prophylaxis reduces the incidence of acute graft-versus-host disease (aGVHD) after alternative donor hematopoietic stem-cell transplantation. METHODS This prospective, multicenter, open-label, randomized trial enrol...

Man Qiao, Bi-Qi Zhou, Yi-Yin Chen et al. · 0 citations
Open access Sep 2026

The circulating tumor microenvironment in small-cell lung cancer: Vimentin-positive circulating tumor endothelial cells as drivers of metastasis and poor prognosis in a large cohort study.

Investigation of the critical role of CD31+ aneuploid circulating tumor endothelial cells expressing vimentin in promoting SCLC metastasis concluded that Vim+ CTECs serve as a key driver of tumor metastasis in SCLC.

Ying Wang, Fei Qi, Ming-Hang Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.